Plutux
$25.15
-3.57%
2026-09-04 12:09:00 EDT-$0.93
Healthcare
Medical - Healthcare Information Services
NASDAQ
Active Trading

Waystar Holding Corp. is dedicated to developing a cloud-based software platform designed to streamline financial transactions within the healthcare industry. Their comprehensive ...

Price Action

$25.15
-3.57%-$0.93
High
Low
52W High-39.4%
Rel. vol
Interval
Range2.6h
VolumeSMA5SMA10
Waystar Holding Corp. (Nasdaq: WAY) is a leading provider of mission-critical cloud-based software for healthcare payments and revenue cycle management. Founded in 2017 through the merger of Navicure and Zirmed, and headquartered in Lehi, Utah, Waystar combines the strengths of established healthcare payment companies to deliver an enterprise-grade platform that ...Waystar Holding Corp. (Nasdaq: WAY) is a leading provider of mission-critical cloud-based software for healthcare payments and revenue cycle management. Founded in 2017 through the merger of Navicure and Zirmed, and headquartered in Lehi, Utah, Waystar combines the strengths of established healthcare payment companies to deliver an enterprise-grade platform that simplifies financial transactions across the healthcare ecosystem. The company serves a diverse clientele, including providers, health systems, and payers, with a footprint that spans the country and processes billions of transactions annually. Waystar's suite of products addresses the full revenue cycle, enhancing operational efficiency and financial performance for its clients. Key offerings include financial clearance for pre-approvals, patient financial care tools for billing and payment plans, claims management and payment posting, denials prevention and recovery, revenue capture optimization, and advanced analytics and reporting. These solutions help reduce administrative burdens, improve claim accuracy, accelerate reimbursements, and increase revenue. Financially, Waystar has demonstrated robust performance. Its business model is characterized by recurring revenue from long-term contracts, contributing to high gross margins. For the trailing twelve months, the company reported a gross profit margin of approximately 69.1%, an EBITDA margin of 35.9%, and a net profit margin of 11.2%. Revenue per share stands at $6.28, with strong free cash flow conversion. The company maintains a solid balance sheet with manageable leverage, and its investment in research and development (5.6% of revenue) underscores its commitment to innovation. Under the leadership of CEO Matthew (Matt) Hawkins, who has been with the company since its inception and previously served at Navicure, Waystar has successfully navigated a public listing in June 2024. The leadership team includes experienced executives such as CFO Alpana Wegner and Chief Transformation Officer Craig Bridge. As part of its strategic focus, Waystar leverages artificial intelligence to enhance its offerings, aiming to provide even greater value to clients. The company's mission is to simplify healthcare payments, and with over 1,700 employees, it continues to expand its market presence and product capabilities. By reducing friction in the revenue cycle, Waystar enables healthcare providers to focus on patient care, ultimately improving the overall healthcare experience.
Founded
2017
Employees
1700
CEO
Matthew J. Hawkins
Full Name
Waystar Holding Corp.
Sector
Healthcare
Industry
Medical - Healthcare Information Services
ROE
3.59%
Market Cap
$4.82B
Current Ratio
1.85
WACC
5.11%
ROIC
3.45%

Contact Information

844-492-9782
1550 Digital Drive, Lehi, UT 84043

Related stocksMedical - Healthcare Information Services

Browse all US stocks

Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer

© Plutux Technology Limited 2026